Biotech

All Articles

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease medicine

.AstraZeneca has actually paid CSPC Pharmaceutical Group $100 million for a preclinical heart attack...

Zephyrm looks for Hong Kong IPO to money stage 3 cell treatment tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, submission (PDF) for an ...

Frazier Lifestyle Sciences collects $630M for small, mid-cap biotechs

.Frazier Life Sciences has sourced an even further $630 million for its own fund concentrated on sma...

GigaGen amasses up to $135M BARDA bucks to beat botox

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own specialist...

GPCR firm Septerna files for IPO on strength of preclinical data

.Septerna will learn how a biotech without "any kind of relevant scientific data" meals in the late ...

Kurma closes first $154M haul for biggest biotech fund as yet

.International VC company Kurma Allies has revealed its latest biotech fund, with 140 million euros ...

Prothena advertises one exec while another keeps-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Editas profit Tip Cas9 licensing civil liberties for $57M

.Against the scenery of a Cas9 license struggle that declines to perish, Editas Medicine is actually...

Ultragenyx changes gene therapy application to dial up efficacy

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson disease genetics treatment UX701 ha...

Biopharma unemployment cost supports in Q3: Ferocious Biotech review

.As summer season heat energy counts on cool down winds, hopes that this year will carry extensive s...